Additionally, many solid tumors, including breast malignancies, glioblastomas, and many others, have NF-κB overexpression that makes them resistant to chemotherapeutic drugs such as tamoxifen and paclitaxel [28,29]. The gene discussed is NFKB1; the disease is glioblastoma.